Decreased TNF-α and NK activity in obsessive-compulsive disorder

Psychoneuroendocrinology

Volumn 29, Issue 7, 2004, Pages 945-952

  Denys, Damiaan ^a   Fluitman, Sjoerd ^a   Kavelaars, Annemieke ^b   Heijnen, Cobi ^b   Westenberg, Herman ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cytokines; Immune system; Obsessive compulsive disorder; Pathophysiology; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD CULTURE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EX VIVO STUDY; FEMALE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; OUTPATIENT; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANALYSIS OF VARIANCE; CYTOKINES; DOWN-REGULATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; MALE; MATCHED-PAIR ANALYSIS; OBSESSIVE-COMPULSIVE DISORDER; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642577307     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2003.08.008     Document Type: Article

References (33)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 1994;American Psychiatric Association, Washington, DC
2. Barber Y., Toren P., Achiron A., Noy S., Wolmer L., Weizman R., Laor N. T cell subsets in obsessive-compulsive disorder. Neuropsychobiology. 34:1996;63-66
3. Brambilla F., Perna G., Bellodi L., Arancio C., Bertani A., Perini G., Carraro C., Gava F. Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol. Psychiatry. 42:1997;976-981
4. Brambilla F., Perna G., Bussi R., Bellodi L. Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation. Psychoneuroendocrinology. 25:2000;301-310
5. Brebner K., Hayley S., Zacharko R., Merali Z., Anisman H. Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology. 22:2000;566-580
6. Carpenter L.L., Heninger G.R., McDougle C.J., Tyrka A.R., Epperson C.N., Price L.H. Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Res. 112:2002;257-262
7. Coryell W.H., Black D.W., Kelly M.W., Noyes R. Jr. HPA axis disturbance in obsessive-compulsive disorder. Psychiatry Res. 30:1989;243-251
8. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., Charney D.S. The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Arch. Gen. Psychiatry. 46:1989;1006-1011
9. Hamilton C.S., Garvey M.A., Swedo S.E. Therapeutic implications of immunology for tics and obsessive-compulsive disorder. Adv. Neurol. 85:2001;311-318
10. Hamilton M. The assesment of anxiety states by rating. Br. J. Med. Psychol. 32:1959;50-55
11. Hasko G., Szabo C., Merkel K., Bencsics A., Zingarelli B., Kvetan V., Vizi E.S. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by dopamine receptor agonists and antagonists in mice. Immunol. Lett. 49:1996;143-147
12. Jenike M.A., Baer L., Minichiello W.E. Obsessive-compulsive disorders. Practical management. 1998;Mosby, St. Louis
13. Koh K.B. Emotion and immunity. J. Psychosom. Res. 45:1998;107-115
14. Kronfol Z., Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry. 157:2000;683-694
15. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 22:2000;370-379
16. Maes M., Meltzer H.Y., Bosmans E. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor and IL-1 beta and IL-6 concentrations. Neuropsychobiology. 30:1994;57-60
17. Marazziti D., Presta S., Pfanner C., Gemignani A., Rossi A., Sbrana S., Rocchi V., Ambrogi F., Cassano G.B. Immunological alterations in adult obsessive-compulsive disorder. Biol. Psychiatry. 46:1999;810-814
18. Mittleman B.B., Castellanos F.X., Jacobsen L.K., Rapoport J.L., Swedo S.E., Shearer G.M. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J. Immunol. 159:1997;2994-2999
19. Monteleone P., Catapano F., Fabrazzo M., Tortorella A., Maj M. Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology. 37:1998;182-185
20. Mossner R., Heils A., Stober G., Okladnova O., Daniel S., Lesch K.P. Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem. Int. 33:1998;251-254
21. Murphy T.K., Goodman W.K., Fudge M.W., Williams R.C. Jr., Ayoub E.M., Dalal M., Lewis M.H., Zabriskie J.B. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am. J. Psychiatry. 154:1997;402-407
22. Perlmutter S.J., Leitman S.F., Garvey M.A., Hamburger S., Feldman E., Leonard H.L., Swedo S.E. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. 354:1999;1153-1158
23. Petitto J.M., Repetto M.J., Hartemink D.M. Brain-immune interactions in neuropsychiatry: Highlights of the basic science and relevance to pathogenetic factors and epiphenomena. CNS Spectr. 6:2001;383-391
24. Ravindran A.V., Griffiths J., Merali Z., Anisman H. Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. J. Affect. Disord. 52:1999;1-10
25. Ritchie P.K., Ashby M., Knight H.H., Judd A.M. Dopamine increases interleukin 6 release and inhibits tumor necrosis factor release from rat adrenal zona glomerulosa cells in vitro. Eur. J. Endocrinol. 134:1996;610-616
26. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. 59:(Suppl. 20):1998;22-33
27. Sobin C., Blundell M.L., Weiller F., Gavigan C., Haiman C., Karayiorgou M. Evidence of a schizotypy subtype in OCD. J. Psychiatr. Res. 34:2000;15-24
28. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., Lougee L., Dow S., Zamkoff J., Dubbert B.K. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry. 155:1998;264-271
29. Theodoropoulou S., Spanakos G., Baxevanis C.N., Economou M., Gritzapis A.D., Papamichail M.P., Stefanis C.N. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Schizophr. Res. 47:2001;13-25
30. Tizabi Y., Louis V.A., Taylor C.T., Waxman D., Culver K.E., Szechtman H. Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder. Biol. Psychiatry. 51:2002;164-171
31. Weizman R., Laor N., Barber Y., Hermesh H., Notti I., Djaldetti M., Bessler H. Cytokine production in obsessive-compulsive disorder. Biol. Psychiatry. 40:1996;908-912
32. Yamada K., Iida R., Miyamoto Y., Saito K., Sekikawa K., Seishima M., Nabeshima T. Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior. J. Neuroimmunol. 111:2000;131-138
33. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15:2001;199-226